Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2016 - 2021)
Anika Therapeutics has reported Change in Acquisitions & Divestments over the past 7 years, most recently at $2.5 million for Q1 2021.
- Quarterly Change in Acquisitions & Divestments fell 83.32% to $2.5 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2021, down 94.44% year-over-year, with the annual reading at $2.5 million for FY2021, 94.44% down from the prior year.
- Change in Acquisitions & Divestments was $2.5 million for Q1 2021 at Anika Therapeutics, down from $18.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $58.8 million in Q4 2019 and troughed at $2.5 million in Q1 2021.
- The 5-year median for Change in Acquisitions & Divestments is $11.5 million (2018), against an average of $16.6 million.
- Year-over-year, Change in Acquisitions & Divestments skyrocketed 411.06% in 2019 and then crashed 83.32% in 2021.
- A 5-year view of Change in Acquisitions & Divestments shows it stood at $10.2 million in 2017, then increased by 12.2% to $11.5 million in 2018, then skyrocketed by 411.06% to $58.8 million in 2019, then crashed by 69.37% to $18.0 million in 2020, then tumbled by 86.11% to $2.5 million in 2021.
- Per Business Quant, the three most recent readings for ANIK's Change in Acquisitions & Divestments are $2.5 million (Q1 2021), $18.0 million (Q4 2020), and $7.0 million (Q3 2020).